Table 2.
Factors associated with a risk of stunting in the study population.
| Variables | OR | CI 95% | p |
|---|---|---|---|
| Underweight, WAZ | |||
| Hepatomegaly | <0.05 | ||
| Absence | 1 | ||
| Presence | 1.4 | 1–1.8 | |
| TAZ, risk of wasting | |||
| Number of sickle cell crises/year | <0.01 | ||
| ≤2 | 1 | — | |
| >2 | 3.8 | 1.5–9.5 | |
| Age at the first transfusion | <0.01 | ||
| >12 months | 1 | — | |
| ≤12 months | 3.3 | 1.1–9.3 | |
| Number of blood transfusions | <0.05 | ||
| ≤3 | 1 | — | |
| >3 | 2.5 | 1.1–6 | |
| Risk of short stature | |||
| Hand-foot syndrome | <0.01 | ||
| Absence | 1 | — | |
| Present | 4.3 | 1.3–13.7 | |
| Number of blood transfusions | <0.05 | ||
| ≤3 | 1 | — | |
| >3 | 4.8 | 1.1–21.5 | |
| Hepatomegaly | <0.05 | ||
| Absence | 1 | — | |
| Presence | 4.2 | 0.94–18.9 | |
| Wasting WHZ | |||
| Hand-foot syndrome | <0.01 | ||
| Absence | 1 | — | |
| Present | 1.7 | 1.2–2.5 | |
| Severe infections | <0.05 | ||
| Absence | 1 | — | |
| Presence | 1.8 | 1.0–3.1 | |
| Number of blood transfusions | <0.05 | ||
| ≤3 | 1 | — | |
| >3 | 1.3 | 1.0–1.7 |